Histopathological spectrum of Leprosy – A prospective study
Authors/Creators
- 1. Professor and Head, department of Dermatology, Venereology and Leprosy (DVL), Mamata Academy of Medical Sciences, Bachupally, Hyderabad, Telangana
- 2. Associate Professor, department of Dermatology, Venereology, Leprosy (DVL), Government Medical College and General Hospital, Survey No. 237, Uyyalawada Village, Nagarkurnool, Telangana
- 3. Associate Professor, department of Dermatology, Venereology and Leprosy (DVL), Mamata Academy of Medical Sciences, Bachupally, Hyderabad, Telangana
- 4. Associate Professor, department of Dermatology, Venereology and Leprosy (DVL), Guntur Medical College and Government General Hospital, Kanna Vari Thota, Guntur, Andhra Pradesh
- 5. Senior Resident, Department of Dermatology, Venereology and Leprosy (DVL), Mamata Academy of Medical Sciences, Bachupally, Hyderabad, Telangana
Description
Introduction: Leprosy, caused by Mycobacterium leprae, remains a major public health issue in developing countries, affecting various organs. Multi-drug therapy (MDT) has significantly reduced cases, including Dapsone-resistant strains. Leprosy lesions are classified based on immune response into five types. This study aims to explore the histological types of leprosy. Methods: This prospective study, conducted at Mamata Academy of Medical Sciences, Hyderabad, from January 2023 to August 2024, included clinically diagnosed or suspected leprosy cases aged >18 years. Demographic data, clinical findings, and skin biopsies were recorded. Histopathological analysis, using H&E and Fite-Faraco staining, followed Ridley-Jopling classification and bacillary index. Results: Out of 52 leprosy cases, the majority (53.8%) were aged 21–40 years, with a male-to-female ratio of 1.3. Hypopigmented patches were the most common clinical finding (61.5%), followed by erythematous lesions (28.8%) and nerve thickening (9.6%). Histologically, BT was the most frequent type (34.6%), followed by BL (23.1%). Conclusion: This study highlights the importance of histopathological classification in leprosy diagnosis. The most common histological types were BT and BL, with strong clinical and histopathological correlation, especially for TT. Early diagnosis and appropriate treatment, including MDT, remain crucial in managing leprosy and preventing further complications.
Abstract (English)
Introduction: Leprosy, caused by Mycobacterium leprae, remains a major public health issue in developing countries, affecting various organs. Multi-drug therapy (MDT) has significantly reduced cases, including Dapsone-resistant strains. Leprosy lesions are classified based on immune response into five types. This study aims to explore the histological types of leprosy. Methods: This prospective study, conducted at Mamata Academy of Medical Sciences, Hyderabad, from January 2023 to August 2024, included clinically diagnosed or suspected leprosy cases aged >18 years. Demographic data, clinical findings, and skin biopsies were recorded. Histopathological analysis, using H&E and Fite-Faraco staining, followed Ridley-Jopling classification and bacillary index. Results: Out of 52 leprosy cases, the majority (53.8%) were aged 21–40 years, with a male-to-female ratio of 1.3. Hypopigmented patches were the most common clinical finding (61.5%), followed by erythematous lesions (28.8%) and nerve thickening (9.6%). Histologically, BT was the most frequent type (34.6%), followed by BL (23.1%). Conclusion: This study highlights the importance of histopathological classification in leprosy diagnosis. The most common histological types were BT and BL, with strong clinical and histopathological correlation, especially for TT. Early diagnosis and appropriate treatment, including MDT, remain crucial in managing leprosy and preventing further complications.
Files
IJTPR,Vol14,Issue12,Article30.pdf
Files
(316.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:282ed8c0f321b5ebe738b8833aab12ec
|
316.9 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-12-28
Software
References
- 1. Katoch, Vishwa Mohan. Eradication of leprosy from India: Reflections on past, present & future. Ind. J Of Med Res. 2024; 159(1): 1 – 5. 2. Kumar SS, Yadav N, Yadav A, Srivastava M, Kumar S, Jain A. Leprosy in Post-elimination Era: A Study Conducted in Rural Tertiary Settings in North India. Cureus. 2024; 16(5): e59464. 3. Alrehaili J. Leprosy Classification, Clinical Features, Epidemiology, and Host Immunological Responses: Failure of Eradication in 2023. Cureus. 2023; 15(9): e44767. 4. Sandeep Kodali, Lohita M, K. S. B. Vaishnavi, Sompalli Suryanarayana, Geetakiran Arakkal, T Jaya Chandra. A study to find the correlation between Sociodemographic factors and Leprosy. Int J Of Phar and Clin Res. 2023; 15(9): 851 – 3. 5. Masatkar V, Meena M, Makhija R, Agarwal C, Balai M. Clinico-Epidemiological Trends of Leprosy at a Tertiary Care Centre of South Rajasthan: A 10-Year Retrospective Study. Indian J Dermatol. 2023; 68(6): 723. 6. Reny Nugraheni, Bhisma Murti, Muhammad E, et al. Effect of hope, spirituality and social support on quality of life among people affected by leprosy in Indonesia: A crosssectional study; Leprosy Review; 2023; 94: 332 – 40. 7. Rodrigues LC, Lockwood DNj. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis. 2011; 11(6): 464 – 70. 8. Ankad B, Sharma A, Vinay K, Rathod S, Mehta H, Bhat YJ, et al. Dermatoscopic evaluation of leprosy: A multi-centre crosssectional study. Indian J Dermatol Venereol Leprol. 2024; 90: 486 – 93. 9. Alrehaili J. Leprosy Classification, Clinical Features, Epidemiology, and Host Immunological Responses: Failure of Eradication in 2023. Cureus. 2023; 15(9): e44767. 10. Patel V, Ahuja R, Arava SK, Khandpur S, Bhari N, Gupta V, Ramam M. A Retrospective Study of the Histopathological Spectrum of Erythema Nodosum Leprosum. Indian Dermatol Online J. 2024; 15(5): 779 – 86. 11. Froes LAR Jr, Trindade MAB, Sotto MN. Immunology of leprosy. Int Rev Immunol. 2022; 41(2): 72 – 83. 12. de Carvalho Dornelas B, da Costa WVT, de Abreu JPF, et al. Role of histopathological, serological, and molecular findings for the early diagnosis of treatment failure in leprosy. BMC Infect Dis. 2024; 24: 1085. 13. Sehgal VN, Sharma S. Borderline tuberculoid evolving across the leprosy spectrum. Skinmed. 2013; 11(1): 49 – 50. 14. Mukherjee M, Ghatak D, Bhunia D, et al. A study on the multidisciplinary diagnostic approach of leprosy: Can we prevent the recrudescence in the post-elimination Indian scenario? J Family Med Prim Care. 2023; 12(9): 2008 – 13. 15. Kumari K, Asotra S, Gupta A, et al. Correlation between Clinical and Histopathological Diagnosis and Classification of Hansen's Disease - A Seven Year Retrospective Study from Himachal Pradesh, India. Indian J Lepr. 2024; 96: 9 – 16. 16. Joshi R. Limitations of histopathology in diagnosis and management of patients with leprosy. Indian J Dermatol Venereol Leprol 2014; 80: 389 – 91.